Delivery Order SPE2DB22D1106-SPE2DB25FEZK0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,633.77 to AmerisourceBergen Drug Corp for the supply of Timolol 0.25% Gel-Solution 5ML, an ophthalmic medication used to treat glaucoma and ocular hypertension. The contract, awarded on July 11, 2025, with an ultimate completion date of July 14, 2025, was competitively awarded without set-aside designation under firm fixed-price terms. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,963.88 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML, an ophthalmic medication commonly used to treat glaucoma and ocular hypertension. The contract, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,540.02 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor...
- The Defense Logistics Agency awarded a delivery order valued at $10,886.71 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Timolol is a beta-blocker medication commonly used to treat glaucoma and ocular...
- The Defense Logistics Agency awarded a delivery order valued at $11,953.10 to AmerisourceBergen Drug Corp for Timolol 0.5% gel-solution in 5ml units. This non-competitive, firm fixed-price delivery order was issued on June 18, 2025, with an ultimate completion date of June 20, 2025. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Timolol is a beta-blocker medication primarily used for glaucoma treatment and post-operative eye care,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Timolol 0.5% Gel-Solution in 5ml units, with a contract ceiling value of $4,887.48. This is a firm fixed price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Timolol 0.5% Gel-Solution in 5ml units, with a ceiling value of $1,217.05. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Timolol 0.5% Gel-Solution in 5mL units, with a ceiling value of $1,733.29. This is a firm fixed price delivery order with an ultimate completion date of May 2, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was awarded competitively with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,514.00 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Timolol 0.25% Gel-Solution 5ML. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Timolol 0.5% gel-solution in 5ml units, with a ceiling value of $2,263.62 and a firm fixed price structure. This delivery order, which is not set-aside and represents a competitively awarded contract, will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 23, 2025. The contract is a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZK0Delivery Order
The Defense Logistics Agency awarded a delivery order contract valued at $31,449.71 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML, a topical ophthalmic medication used in treating glaucoma and ocular hypertension. This firm fixed price delivery order was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its extensive portfolio of brand-name and generic medications across multiple therapeutic domains, positions the company as a critical vendor for federal medical procurement needs within the military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.4k | 7/23/25 |